In tumor cells, IL-6 enriched EVsMMA-MRC5 activates IL-6/JAK/STAT3 and TGFβ signaling, promoting EMT and the acquisition of pro-aggressive traits (Fig. 6). Here, TGFB1 is linked to neoplasm.